fenoldopam has been researched along with Disease Models, Animal in 13 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "0 microg kg(-1) min(-1)) or saline on renal blood flow and function in 10 anaesthetized Labrador dogs in whom rhabdomyolysis and myoglobinuric acute renal failure had been induced by administration of glycerol 50% (10mL kg(-1)) intramuscularly." | 7.72 | Effects of fenoldopam on renal blood flow and its function in a canine model of rhabdomyolysis. ( Corcoran, T; Markos, F; Murray, C; Parfrey, N; Shorten, GD; Snow, HM, 2003) |
| "Fenoldopam (SKF 82526 J) is a selective DA-1 receptor agonist and thus of a potential benefit for promoting afterload reduction, renal vasodilatation, and diuresis in congestive heart failure." | 7.67 | Beneficial effects of fenoldopam on systemic and regional hemodynamics in rabbits with congestive heart failure. ( Jover, BF; McGrath, BP, 1988) |
| "1 microg/kg/min of fenoldopam, unilateral renal ischemia (1 hour, left renal artery cross-clamping) followed by 4 hours of reperfusion, and unilateral renal I/R with fenoldopam infusion." | 3.73 | Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of surgical ischemic acute renal failure. ( Aravindan, N; Natarajan, M; Shaw, AD, 2006) |
| "0 microg kg(-1) min(-1)) or saline on renal blood flow and function in 10 anaesthetized Labrador dogs in whom rhabdomyolysis and myoglobinuric acute renal failure had been induced by administration of glycerol 50% (10mL kg(-1)) intramuscularly." | 3.72 | Effects of fenoldopam on renal blood flow and its function in a canine model of rhabdomyolysis. ( Corcoran, T; Markos, F; Murray, C; Parfrey, N; Shorten, GD; Snow, HM, 2003) |
| "The present studies were conducted to: a) comparatively evaluate the effects of clevidipine, a new dihydropyridine calcium antagonist, and fenoldopam, a dopamine (D-1) receptor agonist on basal renal function, and b) to determine the efficacy of these agents in protecting renal function in an experimental model of ischemia/reperfusion (I/R) induced acute renal failure in rats." | 3.71 | Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats. ( Jandhyala, BS; Stephens, CT, 2002) |
| "Fenoldopam (SKF 82526 J) is a selective DA-1 receptor agonist and thus of a potential benefit for promoting afterload reduction, renal vasodilatation, and diuresis in congestive heart failure." | 3.67 | Beneficial effects of fenoldopam on systemic and regional hemodynamics in rabbits with congestive heart failure. ( Jover, BF; McGrath, BP, 1988) |
| "In this model of septic shock, fenoldopam did not improve renal blood flow, worsened microcirculatory alterations, and induced metabolic changes that were indicative of increased glycolysis." | 1.43 | THE EFFECTS OF FENOLDOPAM ON RENAL FUNCTION AND METABOLISM IN AN OVINE MODEL OF SEPTIC SHOCK. ( Creteur, J; De Backer, D; Herpain, A; Hosokawa, K; Post, EH; Su, F; Taccone, FS; Vincent, JL, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Doppalapudi, S | 1 |
| Jain, A | 1 |
| Khan, W | 1 |
| Domb, AJ | 1 |
| Yi, X | 1 |
| Zhang, G | 1 |
| Yuan, J | 1 |
| Post, EH | 1 |
| Su, F | 1 |
| Taccone, FS | 1 |
| Hosokawa, K | 1 |
| Herpain, A | 1 |
| Creteur, J | 1 |
| Vincent, JL | 1 |
| De Backer, D | 1 |
| Wang, JR | 1 |
| Sun, PH | 1 |
| Ren, ZX | 1 |
| Meltzer, HY | 1 |
| Zhen, XC | 1 |
| Murray, C | 1 |
| Markos, F | 1 |
| Snow, HM | 1 |
| Corcoran, T | 1 |
| Parfrey, N | 1 |
| Shorten, GD | 1 |
| Schwarte, LA | 1 |
| Picker, O | 1 |
| Schindler, AW | 1 |
| Fournell, A | 1 |
| Scheeren, TW | 1 |
| Napolitano, LM | 1 |
| Aravindan, N | 1 |
| Natarajan, M | 1 |
| Shaw, AD | 1 |
| Venkatakrishnan, U | 1 |
| Chen, C | 1 |
| Lokhandwala, MF | 1 |
| Stephens, CT | 1 |
| Jandhyala, BS | 1 |
| Jover, BF | 1 |
| McGrath, BP | 1 |
13 other studies available for fenoldopam and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Fenoldopam mesylate for treating psoriasis: A new indication for an old drug.
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Chemistry, Pharmaceutical; Disease Models, Anima | 2020 |
Renoprotective role of fenoldopam pretreatment through hypoxia-inducible factor-1alpha and heme oxygenase-1 expressions in rat kidney transplantation.
Topics: Animals; Apoptosis; Benzazepines; Blood Urea Nitrogen; Cold Ischemia; Creatinine; Cytoprotection; Di | 2013 |
THE EFFECTS OF FENOLDOPAM ON RENAL FUNCTION AND METABOLISM IN AN OVINE MODEL OF SEPTIC SHOCK.
Topics: Animals; Disease Models, Animal; Female; Fenoldopam; Humans; Kidney; Kidney Function Tests; Sheep; S | 2016 |
GSK-3β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia.
Topics: Adjuvants, Immunologic; Animals; beta-Arrestins; Cyclic AMP; Disease Models, Animal; Dopamine Agonis | 2017 |
Effects of fenoldopam on renal blood flow and its function in a canine model of rhabdomyolysis.
Topics: Animals; Antihypertensive Agents; Creatinine; Disease Models, Animal; Dogs; Female; Fenoldopam; Glyc | 2003 |
Dopamine under alpha1-blockade, but not dopamine alone or fenoldopam, increases depressed gastric mucosal oxygenation.
Topics: Animals; Disease Models, Animal; Dogs; Dopamine; Dopamine Antagonists; Drug Interactions; Female; Fe | 2004 |
Optimization of intestinal mucosal oxygenation in shock: a role for medical therapy?
Topics: Animals; Cell Respiration; Disease Models, Animal; Dogs; Dopamine; Fenoldopam; Intestinal Mucosa; Is | 2004 |
Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of surgical ischemic acute renal failure.
Topics: Acute Kidney Injury; Animals; Disease Models, Animal; DNA; Fenoldopam; Follow-Up Studies; Gene Expre | 2006 |
The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dopamine; Dopamine Agonists; Enzyme Inhibitors; | 2000 |
Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats.
Topics: Acute Kidney Injury; Animals; Disease Models, Animal; Dopamine Agonists; Fenoldopam; Glomerular Filt | 2002 |
Beneficial effects of fenoldopam on systemic and regional hemodynamics in rabbits with congestive heart failure.
Topics: Animals; Benzazepines; Cardiac Output; Catecholamines; Cerebrovascular Circulation; Disease Models, | 1988 |